sterivet laboratories ltd said food and drug administration granted expedited review status for its proprietary drug navicon company said future marketability navicon will greatly facilitated receiving expedited review status and company should achieve wide penetration once fda approval for drug received navicon drug designed treat navicular disease which affects feet third all horses aged between five and reuter 